Rapid determination of isocitrate dehydrogenase mutation status of human gliomas by extraction nanoelectrospray using a miniature mass spectrometer

[1]  V. Pirro,et al.  Intraoperative assessment of isocitrate dehydrogenase mutation status in human gliomas using desorption electrospray ionization-mass spectrometry. , 2019, Journal of Neurosurgery.

[2]  R. Tibshirani,et al.  Distinguishing malignant from benign microscopic skin lesions using desorption electrospray ionization mass spectrometry imaging , 2018, Proceedings of the National Academy of Sciences.

[3]  Xiaohao Wang,et al.  Rapid In Situ Profiling of Lipid C═C Location Isomers in Tissue Using Ambient Mass Spectrometry with Photochemical Reactions. , 2018, Analytical chemistry.

[4]  D. Cahill,et al.  Isocitrate dehydrogenase‐mutant glioma: Evolving clinical and therapeutic implications , 2017, Cancer.

[5]  A. Jarmusch,et al.  N-Acetylaspartate and 2-Hydroxyglutarate Assessed in Human Brain Tissue by Mass Spectrometry as Neuronal Markers of Oncogenesis. , 2017, Clinical chemistry.

[6]  Y. Liu,et al.  Using miniature MS system with automatic blood sampler for preclinical pharmacokinetics study. , 2017, Bioanalysis.

[7]  A. Jarmusch,et al.  Analysis of human gliomas by swab touch spray-mass spectrometry: applications to intraoperative assessment of surgical margins and presence of oncometabolites. , 2017, The Analyst.

[8]  Thomas E. Milner,et al.  Nondestructive tissue analysis for ex vivo and in vivo cancer diagnosis using a handheld mass spectrometry system , 2017, Science Translational Medicine.

[9]  A. Jarmusch,et al.  Intraoperative assessment of tumor margins during glioma resection by desorption electrospray ionization-mass spectrometry , 2017, Proceedings of the National Academy of Sciences.

[10]  Jill S Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014 , 2017, Neuro-oncology.

[11]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[12]  A. Mukasa,et al.  Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma. , 2016, Neuro-oncology.

[13]  Walter J. Curran,et al.  Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. , 2016, The New England journal of medicine.

[14]  A. Jarmusch,et al.  Lipid and metabolite profiles of human brain tumors by desorption electrospray ionization-MS , 2016, Proceedings of the National Academy of Sciences.

[15]  Zheng Ouyang,et al.  Paper spray and extraction spray mass spectrometry for the direct and simultaneous quantification of eight drugs of abuse in whole blood. , 2014, Analytical chemistry.

[16]  Isaiah Norton,et al.  Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery , 2014, Proceedings of the National Academy of Sciences.

[17]  A. Jarmusch,et al.  Touch spray mass spectrometry for in situ analysis of complex samples. , 2014, The Analyst.

[18]  Caterina Giannini,et al.  Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Matthew A Kirleis,et al.  Autonomous in situ analysis and real-time chemical detection using a backpack miniature mass spectrometer: concept, instrumentation development, and performance. , 2014, Analytical chemistry.

[20]  Zheng Ouyang,et al.  Mini 12, Miniature Mass Spectrometer for Clinical and Other Applications—Introduction and Characterization , 2014, Analytical chemistry.

[21]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[22]  K. Aldape,et al.  IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection. , 2014, Neuro-oncology.

[23]  Z. Ouyang,et al.  Direct Mass Spectrometry Analysis of Untreated Samples of Ultralow Amounts Using Extraction Nano-Electrospray. , 2013, Analytical methods : advancing methods and applications.

[24]  E. Shaw,et al.  Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Prabha Dwivedi,et al.  Mass spectrometry: recent advances in direct open air surface sampling/ionization. , 2013, Chemical reviews.

[26]  Ovidiu C. Andronesi,et al.  Detection of 2-Hydroxyglutarate in IDH-Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy , 2012, Science Translational Medicine.

[27]  Brandi S. Heath,et al.  Tissue imaging using nanospray desorption electrospray ionization mass spectrometry. , 2012, Analytical chemistry.

[28]  Dinesh Rakheja,et al.  2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated glioma patients , 2011, Nature Medicine.

[29]  Hong Wu,et al.  Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy , 2012, Journal of Neuro-Oncology.

[30]  R. Cooks,et al.  Biological tissue diagnostics using needle biopsy and spray ionization mass spectrometry. , 2011, Analytical chemistry.

[31]  R. Cooks,et al.  Direct analysis of biological tissue by paper spray mass spectrometry. , 2011, Analytical chemistry.

[32]  G. Reifenberger,et al.  Patients with IDH 1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH 1-mutated glioblastomas , and IDH 1 mutation status accounts for the unfavorable prognostic effect of higher age : implications for classification of gliomas , 2010 .

[33]  Wanderson Romão,et al.  Ambient mass spectrometry: bringing MS into the “real world” , 2010, Analytical and bioanalytical chemistry.

[34]  R. McLendon,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[35]  L. Liau,et al.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.

[36]  Huanwen Chen,et al.  What can we learn from ambient ionization techniques? , 2009, Journal of the American Society for Mass Spectrometry.

[37]  Zheng Ouyang,et al.  Miniature mass spectrometers. , 2009, Annual review of analytical chemistry.

[38]  Zheng Ouyang,et al.  Design and characterization of a multisource hand-held tandem mass spectrometer. , 2008, Analytical chemistry.

[39]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[40]  Qingyu Song,et al.  Handheld rectilinear ion trap mass spectrometer. , 2006, Analytical chemistry.

[41]  R. Cody,et al.  Versatile new ion source for the analysis of materials in open air under ambient conditions. , 2005, Analytical chemistry.

[42]  R. Cooks,et al.  Mass Spectrometry Sampling Under Ambient Conditions with Desorption Electrospray Ionization , 2004, Science.